HealthEquity (NASDAQ:HQY) Issues FY 2026 Earnings Guidance

HealthEquity (NASDAQ:HQY) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 3.870-3.950 for the period, compared to the consensus earnings per share estimate of 3.620. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Analyst Ratings Changes

Several research analysts have commented on the company. Jefferies Financial Group raised their price objective on HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a report on Wednesday, September 3rd. JPMorgan Chase & Co. raised their price target on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. BMO Capital Markets assumed coverage on HealthEquity in a report on Thursday, November 13th. They issued a “market perform” rating and a $100.00 price objective for the company. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a report on Thursday. Finally, Barrington Research restated an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $119.86.

HealthEquity Price Performance

HQY opened at $98.64 on Thursday. The firm has a market capitalization of $8.50 billion, a PE ratio of 59.78, a price-to-earnings-growth ratio of 1.47 and a beta of 0.18. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The business’s 50-day moving average is $96.42 and its two-hundred day moving average is $96.88. HealthEquity has a 1 year low of $74.07 and a 1 year high of $116.65.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. The business had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. During the same period in the prior year, the firm posted $0.78 earnings per share. The company’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Research analysts anticipate that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president owned 49,795 shares of the company’s stock, valued at $4,392,416.95. This trade represents a 3.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction on Thursday, November 20th. The stock was sold at an average price of $104.56, for a total value of $156,840.00. Following the transaction, the executive vice president owned 75,479 shares in the company, valued at approximately $7,892,084.24. This trade represents a 1.95% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 10,781 shares of company stock valued at $1,016,707. 1.50% of the stock is owned by insiders.

Institutional Investors Weigh In On HealthEquity

Several institutional investors have recently added to or reduced their stakes in the business. Larson Financial Group LLC increased its holdings in shares of HealthEquity by 24.4% during the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after acquiring an additional 123 shares in the last quarter. iSAM Funds UK Ltd purchased a new stake in HealthEquity during the 3rd quarter worth approximately $117,000. Meiji Yasuda Asset Management Co Ltd. acquired a new position in HealthEquity during the 2nd quarter valued at approximately $217,000. Merit Financial Group LLC raised its holdings in shares of HealthEquity by 8.9% in the third quarter. Merit Financial Group LLC now owns 2,112 shares of the company’s stock worth $200,000 after buying an additional 172 shares during the last quarter. Finally, Advisory Services Network LLC acquired a new stake in shares of HealthEquity during the third quarter worth $207,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.